We are live on
!
Find out more
VCG
Vantage Consulting Group Portfolio holdings
AUM
$19.7M
1-Year Est. Return
280.87%
This Fund
S&P 500
This Quarter
Est. Return
+17.65%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$1.23B
AUM Growth
–
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
86.51%
Top 10 Holdings %
Top 10 Hldgs %
94.5%
Holding
1,884
New
1,883
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$911M |
| 2 |
ADC Therapeutics
ADCT
|
+$55.1M |
| 3 |
KYNB
Kyntra Bio
KYNB
|
+$25.5M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$5.96M |
| 5 |
Kroger
KR
|
+$366K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.04% |
| 2 | Technology | 0.89% |
| 3 | Consumer Discretionary | 0.79% |
| 4 | Industrials | 0.61% |
| 5 | Consumer Staples | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Healthcare Realty
HR
$7.28B
| $2K | ﹤0.01% |
+80
| New | +$2.11K |
|
1652
Huntsman Corp
HUN
$1.71B
| $2K | ﹤0.01% |
+93
| New | +$2.31K |
|
1653
International Bancshares
IBOC
$4.76B
| $2K | ﹤0.01% |
+48
| New | +$1.52K |
|
|
JBGS
1654
JBG SMITH
JBGS
$818M
| $2K | ﹤0.01% |
+59
| New | +$1.7K |
|
1655
Kilroy Realty
KRC
$4.52B
| $2K | ﹤0.01% |
+29
| New | +$1.63K |
|
1656
Lamar Advertising Co
LAMR
$16.2B
| $2K | ﹤0.01% |
+20
| New | +$1.5K |
|
1657
Lennar Class B
LEN.B
$19.4B
| $2K | ﹤0.01% |
+28
| New | +$1.66K |
|
1658
Leslie's
LESL
$8.9M
| $2K | ﹤0.01% |
+3
| New | +$1.35K |
|
1659
Cheniere Energy
LNG
$55.2B
| $2K | ﹤0.01% |
+41
| New | +$2.2K |
|
1660
Lloyds Banking Group
LYG
$89.5B
| $2K | ﹤0.01% |
+995
| New | +$1.68K |
|
1661
Cloudflare
NET
$99B
| $2K | ﹤0.01% |
+22
| New | +$1.44K |
|
1662
NNN REIT
NNN
$9.04B
| $2K | ﹤0.01% |
+41
| New | +$1.54K |
|
1663
Nutanix
NTNX
$16B
| $2K | ﹤0.01% |
+63
| New | +$1.71K |
|
1664
NovoCure
NVCR
$1.73B
| $2K | ﹤0.01% |
+10
| New | +$1.37K |
|
1665
Envista
NVST
$4.44B
| $2K | ﹤0.01% |
+50
| New | +$1.45K |
|
1666
NatWest
NWG
$75.4B
| $2K | ﹤0.01% |
+417
| New | +$1.67K |
|
1667
O-I Glass
OI
$1.1B
| $2K | ﹤0.01% |
+187
| New | +$2.13K |
|
1668
ON Semiconductor
ON
$31.8B
| $2K | ﹤0.01% |
+72
| New | +$2.01K |
|
1669
PagerDuty
PD
$816M
| $2K | ﹤0.01% |
+45
| New | +$1.53K |
|
1670
Planet Fitness
PLNT
$4.42B
| $2K | ﹤0.01% |
+31
| New | +$2.17K |
|
|
P
1671
Everpure Inc
P
$25.7B
| $2K | ﹤0.01% |
+98
| New | +$1.88K |
|
|
ECHO
1672
EchoStar
ECHO
$24.4B
| $2K | ﹤0.01% |
+100
| New | +$2.39K |
|
1673
Virgin Galactic
SPCE
$328M
| $2K | ﹤0.01% |
+4
| New | +$1.87K |
|
|
SPR
1674
DELISTED
Spirit AeroSystems
SPR
| $2K | ﹤0.01% |
+42
| New | +$1.2K |
|
1675
Trustmark
TRMK
$2.76B
| $2K | ﹤0.01% |
+64
| New | +$1.6K |
|
Similar funds
MVG
NCM
FFGIM
PIM
HFG
SWM
ICM
SM
Vantage Consulting Group's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Vantage Consulting Group, which disclosed 1,884 positions worth $1.23B. Its ten largest holdings account for 94% of the portfolio.
Its largest position is Royalty Pharma: 21,477,282 shares worth $1.07B.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, followed by Technology and Consumer Discretionary.
- Vantage Consulting Group's largest Q4 2020 buy was Royalty Pharma: 21,477,282 shares worth $1.07B.
- Vantage Consulting Group's ten largest holdings make up 94% of its $1.23B portfolio in Q4 2020.
- Vantage Consulting Group disclosed 1,884 positions in Q4 2020, its first 13F filing on record.
Based on Vantage Consulting Group's 13F filing for Q4 2020, filed 12 Feb 2021.